2.38 USD
+0.04 (+1.93%)
Last: Jan 30, 2026, 08:00 PM
We assign a fundamental rating of 3 out of 10 to ICU. ICU was compared to 185 industry peers in the Health Care Equipment & Supplies industry. ICU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ICU is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year ICU has reported negative net income.
- ICU had a negative operating cash flow in the past year.
- In the past 5 years ICU always reported negative net income.
- In the past 5 years ICU always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of ICU (-87.99%) is worse than 75.68% of its industry peers.
- ICU has a worse Return On Equity (-119.20%) than 64.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -87.99% | ||
| ROE | -119.2% | ||
| ROIC | N/A |
ROA(3y)-587.39%
ROA(5y)-528.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ICU has a Gross Margin of 95.35%. This is amongst the best in the industry. ICU outperforms 99.46% of its industry peers.
- ICU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 95.35% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, ICU has more shares outstanding
- The debt/assets ratio for ICU has been reduced compared to a year ago.
2.2 Solvency
- ICU has an Altman-Z score of -2.82. This is a bad value and indicates that ICU is not financially healthy and even has some risk of bankruptcy.
- ICU has a worse Altman-Z score (-2.82) than 64.32% of its industry peers.
- There is no outstanding debt for ICU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.82 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- ICU has a Current Ratio of 3.66. This indicates that ICU is financially healthy and has no problem in meeting its short term obligations.
- ICU has a Current ratio of 3.66. This is in the better half of the industry: ICU outperforms 63.78% of its industry peers.
- ICU has a Quick Ratio of 3.64. This indicates that ICU is financially healthy and has no problem in meeting its short term obligations.
- ICU has a better Quick ratio (3.64) than 72.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.64 |
3. Growth
3.1 Past
- ICU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.15%, which is quite impressive.
- The Revenue has grown by 1195.59% in the past year. This is a very strong growth!
EPS 1Y (TTM)32.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
Revenue 1Y (TTM)1195.59%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%169.12%
3.2 Future
- ICU is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.88% yearly.
- Based on estimates for the next years, ICU will show a very strong growth in Revenue. The Revenue will grow by 147.47% on average per year.
EPS Next Y20.49%
EPS Next 2Y25.6%
EPS Next 3Y18.88%
EPS Next 5YN/A
Revenue Next Year601.24%
Revenue Next 2Y229.67%
Revenue Next 3Y147.47%
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ICU. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ICU. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- ICU's earnings are expected to grow with 18.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.6%
EPS Next 3Y18.88%
5. Dividend
5.1 Amount
- No dividends for ICU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
SEASTAR MEDICAL HOLDING CORP / ICU FAQ
Can you provide the ChartMill fundamental rating for SEASTAR MEDICAL HOLDING CORP?
ChartMill assigns a fundamental rating of 3 / 10 to ICU.
What is the valuation status for ICU stock?
ChartMill assigns a valuation rating of 0 / 10 to SEASTAR MEDICAL HOLDING CORP (ICU). This can be considered as Overvalued.
What is the profitability of ICU stock?
SEASTAR MEDICAL HOLDING CORP (ICU) has a profitability rating of 1 / 10.
What is the expected EPS growth for SEASTAR MEDICAL HOLDING CORP (ICU) stock?
The Earnings per Share (EPS) of SEASTAR MEDICAL HOLDING CORP (ICU) is expected to grow by 20.49% in the next year.